UK rejects the Vertex's CF medicine( heard on Bloomberg). Yahoo is inept, no wonder, but Google does not have anything on this either....
D1.FDA decides on Dris before Jan 22: 0.(They want to see how AP for Etep.. goes, that is the only reason for the delay ).
D2. FDA goes negative on Dris.. between Jan22 and Feb 26: 0.8
D3. In case D2 does materialize, FDA approves Etepl: 0.95.
D4. In case Dris. somehow gets the nod from FDA, before Feb 26, FDA approves Etepl. anyway: 0.80
On BMRN: buy in the end of Sept.( was too shy to set PT, but all the others had it around $170...)
On SRPT: $27 PT, down from $33,set a couple of weeks ago.
And, he is brave enough to"explain" the latest developments.
Someone must have a gun to his skull:this is my guess.
Yes, statistics in BMRN press releases is one thing, detailed description of what the patients go through is something else( and injection side reaction is far from the only serious trouble the have to face with dris..).